|
Blanco JR, Morillo R, Abril V, Escobar I, Bernal E, Folguera C, Branas F, Gimeno M, Ibarra O, Iribarren JA, Lazaro A, Marino A, Martin MT, Martinez E, Ortega L, Olalla J, Robustillo A, Sanchez-Conde M, Rodriguez MA, de la Torre J, Sanchez-Rubio J, Tuset M; Gesida and SEFH. Deprescribing of non-antiretroviral therapy in HIV-infected patients. Eur J Clin Pharmacol. 2020 Mar;76(3):305-318. doi: 10.1007/s00228-019-02785-z. Epub 2019 Dec 21. PubMed PMID: 31865412.
AÑO: 2020; IF: 2.953
|
31865412
|
Alejos B, Suarez-Garcia I, Rava M, Bautista-Hernandez A, Gutierrez F, Dalmau D, Sagastagoitia I, Rivero A, Moreno S, Jarrin I; CoRIS. Effectiveness and safety of first-line antiretroviral regimens in clinical practice: a multicentre cohort study. J Antimicrob Chemother. 2020 Oct 1;75(10):3004-3014. doi: 10.1093/jac/dkaa246. PubMed PMID: 32667674.
AÑO: 2020; IF: 5.79
|
|
Migliori GB, Tiberi S, Zumla A, Petersen E, Chakaya JM, Wejse C, Munoz Torrico M, Duarte R, Alffenaar JW, Schaaf HS, Marais BJ, Cirillo DM, Alagna R, Rendon A, Pontali E, Piubello A, Figueroa J, Ferlazzo G, Garcia-Basteiro A, Centis R, Visca D, D'Ambrosio L, Sotgiu G; members of the Global Tuberculosis Network. MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network. Int J Infect Dis. 2020 Mar;92S:S15-S25. doi: 10.1016/j.ijid.2020.01.042. Epub 2020 Feb 4. PubMed PMID: 32032752.
AÑO: 2020; IF: 3.623
|
|
Del Amo J, Polo R, Moreno S, Diaz A, Martinez E, Arribas JR, Jarrin I, Hernan MA; The Spanish HIV/COVID-19 Collaboration. Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy : A Cohort Study. Ann Intern Med. 2020 Oct 6;173(7):536-541. doi: 10.7326/M20-3689. Epub 2020 Jun 26. PubMed PMID: 32589451; PubMed Central PMCID: PMC7394316.
AÑO: 2020; IF: 25.391
|
|
Murray M, Antela A, Mills A, Huang J, Jager H, Bernal E, Lombaard J, Katner H, Walmsley S, Khuong-Josses MA, Hudson K, Dorey D, Griffith S, Spreen W, Vanveggel S, Shaefer M, Margolis D, Chounta V. Patient-Reported Outcomes in ATLAS and FLAIR Participants on Long-Acting Regimens of Cabotegravir and Rilpivirine Over 48 Weeks. AIDS Behav. 2020 Dec;24(12):3533-3544. doi: 10.1007/s10461-020-02929-8. PubMed PMID: 32447500; PubMed Central PMCID: PMC7667137.
AÑO: 2020; IF: 3.895
|